Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/37571
Title: Activation of platelet-activating factor receptor exacerbates renal inflammation and promotes fibrosis
Authors: Correa-Costa, Matheus
Andrade-Oliveira, Vinicius
Braga, Tarcio T.
Castoldi, Angela
Aguiar, Cristhiane F.
Origassa, Clarice Silva Taemi [UNIFESP]
Rodas, Andrea C. D.
Hiyane, Meire I.
Malheiros, Denise M. A. C.
Rios, Francisco J. O.
Jancar, Sonia
Camara, Niels O. S. [UNIFESP]
Universidade de São Paulo (USP)
Universidade Federal de São Paulo (UNIFESP)
Univ Glasgow
Keywords: chronic kidney disease
platelet activating factor receptor
renal fibrosis
renal inflammation
Issue Date: 1-Apr-2014
Publisher: Nature Publishing Group
Citation: Laboratory Investigation. New York: Nature Publishing Group, v. 94, n. 4, p. 455-466, 2014.
Abstract: Platelet-activating factor (PAF) is a lipid mediator with important pro-inflammatory effects, being synthesized by several cell types including kidney cells. Although there is evidence of its involvement in acute renal dysfunction, its role in progressive kidney injury is not completely known. in the present study, we investigated the role of PAF receptor (PAFR) in an experimental model of chronic renal disease. Wild-type (WT) and PAFR knockout (KO) mice underwent unilateral ureter obstruction (UUO), and at kill time, urine and kidney tissue was collected. PAFR KO animals compared with WT mice present: (a) less renal dysfunction, evaluated by urine protein/creatinine ratio; (b) less fibrosis evaluated by collagen deposition, type I collagen, Lysyl Oxidase-1 (LOX-1) and transforming growth factor beta (TGF-beta) gene expression, and higher expression of bone morphogenetic protein 7 (BMP-7) (3.3-fold lower TGF-beta/BMP-7 ratio); (c) downregulation of extracellular matrix (ECM) and adhesion molecule-related machinery genes; and (d) lower levels of pro-inflammatory cytokines. These indicate that PAFR engagement by PAF or PAF-like molecules generated during UUO potentiates renal dysfunction and fibrosis and might promote epithelial-to-mesenchymal transition (EMT). Also, early blockade of PAFR after UUO leads to a protective effect, with less fibrosis deposition. in conclusion, PAFR signaling contributes to a pro-inflammatory environment in the model of obstructive nephropathy, favoring the fibrotic process, which lately will generate renal dysfunction and progressive organ failure.
URI: http://repositorio.unifesp.br/handle/11600/37571
ISSN: 0023-6837
Other Identifiers: http://dx.doi.org/10.1038/labinvest.2013.155
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.